These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 701680)

  • 1. Dietary treatment of tyrosinemia type I: importance of methionine restriction.
    Michals K; Matolon R; Wong PW
    J Am Diet Assoc; 1978 Nov; 73(5):507-14. PubMed ID: 701680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hereditary tyrosinemia: examination of the liver by electron microscopy of hepatic biopsies: observation of 7 cases].
    Tremblay M; Bélanger L; Larochelle J; Privé L; Gagnon PM
    Union Med Can; 1977 Jul; 106(7):1014-6. PubMed ID: 898402
    [No Abstract]   [Full Text] [Related]  

  • 3. Some biochemical effects of chloral hydrate in an infant with a tyrosinemia-like syndrome.
    Watts RW; Chalmers RA; Liberman MM; Lawson AM
    Pediatr Res; 1975 Dec; 9(12):875-8. PubMed ID: 1196703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dietary treatment on the renal tubular function in a patient with hereditary tyrosinemia.
    Suzuki Y; Konda M; Imai I; Imamura H; Shimao S; Okaka T
    Int J Pediatr Nephrol; 1987; 8(3):171-6. PubMed ID: 3429140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dietary management of hereditary tyrosinemia. Apropos of 7 cases].
    Jehan P; Buchman M; Odièvre M
    Ann Pediatr (Paris); 1984 Jan; 31(1):33-40. PubMed ID: 6712098
    [No Abstract]   [Full Text] [Related]  

  • 6. Urinary p-tyramine in hereditary tyrosinemia: I. Levels as compared to normal individuals, effect of diet, and relationship to urinary tyrosine.
    Hoag GN; Hill A; Zaleski W
    Clin Biochem; 1977 Feb; 10(1):24-5. PubMed ID: 837522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a low-protein diet and dietary supplementation of threonine on tyrosine and 2-(2-nitro-4-trifluoromethylbenzoyl) cyclohexane-1,3-dione-induced corneal lesions, the extent of tyrosinemia, and the activity of enzymes involved in tyrosine catabolism in the rat.
    Lock EA; Gaskin P; Ellis MK; Robinson M; Provan WM; Smith LL
    Toxicol Appl Pharmacol; 1998 May; 150(1):125-32. PubMed ID: 9630461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association, in the same subject, of deletion of the short arm of chromosome 4 (4p-) and of complete deficiency of parahydroxyphenyl-pyruvate oxidase activity in the liver (tyrosinosis)].
    Malpuech G; Mattei JF; Gaulme J; Palcoux JB; Lesec G; Vanlieferinghen P
    J Genet Hum; 1981 Dec; 29(4):455-61. PubMed ID: 7328420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hereditary tyrosinemia type III].
    Endo F
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):137-40. PubMed ID: 9590008
    [No Abstract]   [Full Text] [Related]  

  • 10. A patient with tyrosinemia and hypermethioninemia.
    Partington MW; Haust MD
    Can Med Assoc J; 1967 Oct; 97(18):1059-67. PubMed ID: 6050907
    [No Abstract]   [Full Text] [Related]  

  • 11. Four-hydroxyphenylpyruvic acid oxidase deficiency with normal fumarylacetoacetase: a new variant form of hereditary hypertyrosinemia.
    Endo F; Kitano A; Uehara I; Nagata N; Matsuda I; Shinka T; Kuhara T; Matsumoto I
    Pediatr Res; 1983 Feb; 17(2):92-6. PubMed ID: 6828337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemia.
    Hostetter MK; Levy HL; Winter HS; Knight GJ; Haddow JE
    N Engl J Med; 1983 May; 308(21):1265-7. PubMed ID: 6188953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary tyrosinemia type I--an overview.
    Kvittingen EA
    Scand J Clin Lab Invest Suppl; 1986; 184():27-34. PubMed ID: 3296130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosinemia without liver or renal damage with plantar and palmar keratosis and keratitis (hypertyrosinemia type II).
    Pelet B; Antener I; Faggioni R; Spahr A; Gautier E
    Helv Paediatr Acta; 1979 May; 34(2):177-83. PubMed ID: 156708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme defect in a case of tyrosinemia type I, acute form.
    Furukawa N; Kinugasa A; Seo T; Ishii T; Ota T; Machida Y; Inoue F; Imashuku S; Kusunoki T; Takamatsu T
    Pediatr Res; 1984 May; 18(5):463-6. PubMed ID: 6145143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Juvenile form of tyrosinemia type I].
    Nothjunge J; Rosendahl W
    Klin Padiatr; 1989; 201(6):458-63. PubMed ID: 2601281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A rare cause of neonatal hyperphenylalaninemia: tyrosinemia type I].
    Sarles J; Maurin N; Giraud F
    Pediatrie; 1992; 47(12):809-11. PubMed ID: 1338924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promising new treatment for type I tyrosinemia.
    Heubi JE
    J Pediatr Gastroenterol Nutr; 1993 Oct; 17(3):340-1. PubMed ID: 8271141
    [No Abstract]   [Full Text] [Related]  

  • 19. Dietary restriction in inborn errors of amino acid metabolism.
    Bickel H
    Curr Concepts Nutr; 1979; 8():35-53. PubMed ID: 527358
    [No Abstract]   [Full Text] [Related]  

  • 20. [Other abnormalities of tyrosine metabolism].
    Endo F
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):144-5. PubMed ID: 9590010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.